Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-55,000
Closed -$2.88M 1111
2023
Q4
$2.88M Hold
55,000
0.01% 668
2023
Q3
$2.98M Hold
55,000
0.01% 643
2023
Q2
$3.11M Sell
55,000
-29,000
-35% -$1.67M 0.01% 645
2023
Q1
$5.08M Buy
84,000
+2,000
+2% +$134K 0.02% 561
2022
Q4
$5.35M Buy
82,000
+3,440
+4% +$222K 0.02% 577
2022
Q3
$3.91M Buy
78,560
+28,560
+57% +$1.73M 0.02% 630
2022
Q2
$3.12M Buy
+50,000
New +$3.37M 0.01% 690

Other funds holding THRM

Axa's THRM Position: Q1 2024 in Review

Axa sold out of Gentherm (THRM) in Q1 2024, closing a stake of 55,000 shares — an estimated $2.88M sold.

Axa first reported a position in THRM in Q2 2022 and held it in 7 quarters. The position peaked at $5.35M in Q4 2022. 239 funds tracked by Wall St. Rank hold THRM as of Q1 2024.

  • Axa reported no remaining Gentherm position as of Q1 2024 after selling out during the quarter.
  • Axa sold 55,000 Gentherm shares in Q1 2024, an estimated $2.88M.
  • Axa first reported a position in Gentherm in Q2 2022 and held it in 7 quarters.
  • Axa's Gentherm position peaked at $5.35M in Q4 2022.
  • 239 funds tracked by Wall St. Rank held Gentherm as of Q1 2024.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.